J.P.
JP Morgan analyst Joseph Greff weighed in on Wynn Resorts, Limited (NASDAQ:WYNN), downgrading the stock from Overweight to Neural and lowering his price …
Analysts are weighing in on biotech companies bluebird bio Inc (NASDAQ:BLUE) and Agios Pharmaceuticals Inc. (NASDAQ:AGIO), with mixed ratings.
Cyber security company CyberArk Software Ltd (NASDAQ:CYBR) posted second quarter 2015 earnings results on August 12, triggering mixed reviews from Wall Street analysts. …
Biopharmaceutical company MannKind Corporation (NASDAQ:MNKD) impressed investors after posting second-quarter earnings yesterday before market open, sending shares up as much as 12% MannKind narrowly beat the …
Move over Pandora and Spotify—Apple Inc (NASDAQ:AAPL) is about to enter the music industry. At least that’s the opinion shared by UBS analyst …
In a research report published Monday, JP Morgan analyst Cory Kasimov maintained an Overweight rating on Vertex Pharmaceuticals (NASDAQ:VRTX) with a price target …
In a research report released today, J.P.
In a research report issued today, J.P.
In a research note issued today, J.P.
